Fusion Antibodies PLC (FAB)

ORD 4P

Sell: 12.50p|Buy: 13.50p|Change: 0.71 (-5.07%)

Open

14.00p

Previous close

14.00p

Trade high

14.50p

Volume

440,908

Year high

21.00p

Year low

5.60p

Dividend yield

–

Market capitalisation

£15.10 mn

P/E ratio

–

ISIN

GB00BDQZGK16

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPPand can be used with Dividend reinvestment

Share price

Performance 19/12/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
Fusion Antibodies PLC	- 8.20
FTSE AIM All Share	+ 0.65
More...

Company profile

Fusion Antibodies PLC is a Contract Research Organisation (CRO) providing antibody identification, engineering, and expression services for the discovery and development of antibodies for human and veterinary therapeutics, as well as for diagnostics. Its customers are pharmaceutical, biotech, veterinary, diagnostic, and life science research companies. The company's three core service areas include: Discovery (identification, screening, and sequencing of novel antibodies); Engineering (optimising the performance of antibodies); and Supply (production and purification of antibodies for further development). Geographically company generates the majority of its revenue from North America and the Rest of the World, followed by the United Kingdom and the Rest of Europe.

Sector

Healthcare

News

Recent trades

Date	Time	Price	Quantity	Value (£)
22/12/2025	10:25:06	13.29	3	0.40
22/12/2025	10:04:59	13.125	36,502	4,790.89
22/12/2025	10:03:47	12.83	11,142	1,429.52
22/12/2025	09:57:05	13.15	36,873	4,848.80
22/12/2025	09:56:45	12.7	30,000	3,810.00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.